Literature DB >> 26131137

The role of leptin in the ventricular remodeling process and its mechanism.

Guoxing Zuo1, Xinping Du1, Liuying Zheng1, Cuancuan Wang1, Kuan Wang1, Ying Li1.   

Abstract

OBJECTIVE: This study aims to explore the role of leptin in the ventricular remodeling process and its mechanism in the diabetic rats' model.
METHODS: The diabetic SD rats model induced by streptozotocin was established. The SD rats were randomly divided into 4 groups: control group (20 rats treated with citric acid/sodium citrate buffer); M0 group (10 rats treated with physiological saline); M1 group (10 rats treated with 50 μg/kg LP); M2 group (10 rats treated with 100 μg/kg LP). Ang-II was detected by ELISA. The expression levels of LP and Ob-Rb were detected by RT-PCR. MAPK phosphorylation changes were detected by western blotting. Myocardial morphology was observed.
RESULTS: Compared with control group, the blood glucose concentration and Ang-II significantly increased in diabetic model groups (P < 0.01) and body weight decreased (P < 0.05). The expression levels of LP and Ob-Rb increased and heart function decreased in diabetic model groups.
CONCLUSIONS: LP may be involved in the myocardial cell hypertrophy through the neuroendocrine system and associated with the JAK-STAT, Ras-Raf-MEK-MAPK and PI-3K signaling pathway, which provides a new concept for the pathogenesis of cardiac hypertrophy.

Entities:  

Keywords:  Angiotensin II; Leptin; MAPK; Ob-Rb; streptozotocin; ventricular remodeling

Year:  2015        PMID: 26131137      PMCID: PMC4483875     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

Review 1.  On the local cardiac renin angiotensin system. Basic and clinical implications.

Authors:  Walmor C De Mello; Edward D Frohlich
Journal:  Peptides       Date:  2011-06-25       Impact factor: 3.750

Review 2.  Selective insulin and leptin resistance in metabolic disorders.

Authors:  A Christine Könner; Jens C Brüning
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

3.  Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative stress.

Authors:  Enas A Hamed; Madeha M Zakary; Nagwa S Ahmed; Rania M Gamal
Journal:  Diabetes Res Clin Pract       Date:  2011-09-15       Impact factor: 5.602

4.  Leptin's regulation of obesity-induced cardiac extracellular matrix remodeling.

Authors:  Sherma Zibadi; Felina Cordova; Elise H Slack; Ronald R Watson; Douglas F Larson
Journal:  Cardiovasc Toxicol       Date:  2011-12       Impact factor: 3.231

5.  Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus.

Authors:  Sheela N Magge
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-09-25

6.  Relation of serum leptin with cardiac mass and left atrial dimension in individuals >70 years of age.

Authors:  Wolfgang Lieb; Lisa M Sullivan; Jayashri Aragam; Tamara B Harris; Ronenn Roubenoff; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2009-06-18       Impact factor: 2.778

7.  Diabetic cardiomyopathy--fact or fiction?

Authors:  B Maisch; P Alter; S Pankuweit
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

8.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

Review 9.  Leptin signaling.

Authors:  Hyeong-Kyu Park; Rexford S Ahima
Journal:  F1000Prime Rep       Date:  2014-09-04

10.  Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin.

Authors:  Kamal Rahmouni; Curt D Sigmund; William G Haynes; Allyn L Mark
Journal:  Diabetes       Date:  2008-12-09       Impact factor: 9.461

View more
  1 in total

Review 1.  Exploring the Crosstalk between Adipose Tissue and the Cardiovascular System.

Authors:  Ioannis Akoumianakis; Nadia Akawi; Charalambos Antoniades
Journal:  Korean Circ J       Date:  2017-09-21       Impact factor: 3.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.